ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  Related Studies  
Dietary Phytoestrogens and Bone Metabolism

This study has been completed.

Sponsored by: National Center for Complementary and Alternative Medicine (NCCAM)
Information provided by: National Center for Complementary and Alternative Medicine (NCCAM)
ClinicalTrials.gov Identifier: NCT00010686
  Purpose

The purpose of this study is to determine whether dietary phytoestrogens are an effective alternative to postmenopausal exogenous estrogen replacement therapy in preventing bone loss.


Condition Intervention Phase
Osteoporosis
Drug: Dietary Phytoestrogens
Phase II

MedlinePlus related topics:   Osteoporosis   

U.S. FDA Resources

Study Type:   Interventional
Study Design:   Treatment, Randomized
Official Title:   Dietary Phytoestrogens and Bone Metabolism

Further study details as provided by National Center for Complementary and Alternative Medicine (NCCAM):

Estimated Study Completion Date:   December 2005

Detailed Description:

Osteoporosis in postmenopausal women is one of the most important public health challenges of our time. With millions of women affected and billions of dollars being spent for its complications, we need to develop effective approaches to this disease. Postmenopausal women are at particular risk because the loss of estrogen associated with the menopause leads to bone loss of much greater magnitude than one would expect on the basis of age alone. Estrogen replacement therapy, a logical and effective therapeutic approach, has been associated with serious concerns about adverse events and, thus, limited use. The recent development of selective estrogen receptor modulators (SERMS) may help if they continue to show promise. Interest in natural sources of estrogenic substances to prevent postmenopausal bone loss is an expected outgrowth of the general interest in alternative medicinals for a wide variety of human disorders. Concerns about the potential for adverse consequences of the conventional use of estrogen replacement therapy, and limited knowledge about long term use of SERMS- add support to this quest. No systematic investigation of the role of dietary phytoestrogens on bone mass and skeletal dynamics has yet been conducted. With the dramatic increase in interest in these sources of estrogenic activity, it is important for us to determine whether these agents are efficacious. Otherwise, this field will be plagued for years to come by incomplete, anecdotal and scientifically poorly documented actions of these agents on bone metabolism. It is our expectation that this study will begin to provide the documentary information that the field so clearly needs. The rationale for exploring the potential for phytoestrogens in the maintenance of skeletal health in postmenopausal women is clear and compelling.

Women will be randomly assigned to one of three healthy eating plans and, over the course of the year-long study, will learn to choose and cook foods to help optimize health as they go through menopause and beyond.

  Eligibility
Ages Eligible for Study:   50 Years to 72 Years
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes

Criteria

Inclusion Criteria:

  • Postmenopausal
  • Weight within 90% to 120% of ideal body weight
  • 12 or more months since last menstrual period
  • New York Metro Area resident

Exclusion Criteria:

  • History of cancer, diabetes, or heart disease
  • Smoker
  Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00010686

Locations
United States, New York
Columbia University/Health Science Division    
      New York, New York, United States, 10032

Sponsors and Collaborators

Investigators
Principal Investigator:     Dr. John P. Bilezikian     Columbia University    
  More Information

Study ID Numbers:   P50 AT000090-01P2, P50 AT000090-01
First Received:   February 2, 2001
Last Updated:   August 17, 2006
ClinicalTrials.gov Identifier:   NCT00010686
Health Authority:   United States: Federal Government

Study placed in the following topic categories:
Musculoskeletal Diseases
Osteoporosis
Bone Diseases, Metabolic
Bone Diseases

ClinicalTrials.gov processed this record on September 05, 2008




Links to all studies - primarily for crawlers